---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-127626"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:42:01.703624+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Annovis Bio presents investor deck on path to NDA for Alzheimer's and Parkinson's

## Summary
- Presentation on December 11, 2024 outlines development path to NDA for Alzheimer's and Parkinson's.
- Deck used during live webcast; full content not available in this filing excerpt.
- No specific clinical data, financial figures, or milestone dates disclosed in the provided text.

## SEC filing metadata
- accession: 0001104659-24-127626
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465924127626/0001104659-24-127626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924127626/tm2430782d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-127626
- JSON: https://secwatch.observer/filing/0001104659-24-127626.json
- Plain text: https://secwatch.observer/filing/0001104659-24-127626.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.